[schwank]

"When patents expire, you'll see many generics come onto the market at reduced costs, and cost to consumer goes down."

This assertion is simply not true. A prime example - Insulin is 100 years old. Those who need it are paying sky high prices due to corporate greed, and many simply can't afford it. No competition, no affordable option. People are dying due to this greed.

[johncolanduoni]

You’ve picked one large-molecule therapeutic which has significant variations between different products and much higher production costs. The vast majority of drugs are nothing like it, and they follow the pattern of a dramatic drop in price once generics can be legally sold.

[adam_arthur]

Hmm, this article seems to disagree.

"The U.S. Food and Drug Administration approved Semglee, a biosimilar form of insulin."

"As a generic, it can be automatically swapped for the price brand-name versions to help patients save money."

https://www.verywellhealth.com/fda-allows-generic-swap-for-b...